Ignite Creation Date:
2024-05-06 @ 8:20 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02717962
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2016-03-16
Brief Title:
Study of VAL-083 in Patients With MGMT Unmethylated Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
Sponsor:
Kintara Therapeutics Inc
Organization:
Kintara Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-16
First Submit QC Date:
March 18 2016
Study First Post Date:
2016-03-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2023-11-22
Last Update Post Date Type:
ACTUAL